by | Jun 27, 2024 | Publications
Cancers (Basel). 2024 Jun 19;16(12):2263. doi: 10.3390/cancers16122263. ABSTRACT The outcome of multiple myeloma (MM) has significantly improved in the last few decades due to several factors such as new biological discoveries allowing to better stratify disease risk,...
by | Jun 27, 2024 | Publications
Int J Mol Sci. 2024 Jun 11;25(12):6431. doi: 10.3390/ijms25126431. ABSTRACT Based on the lack of differences in progression-free and overall survival after a median follow-up of 93 months in our HOVON-65/GMMG-HD4 trial (German part; n = 395) randomizing VAD induction...
by | Jun 27, 2024 | Publications
Front Oncol. 2024 Jun 11;14:1404744. doi: 10.3389/fonc.2024.1404744. eCollection 2024. ABSTRACT BACKGROUND: Multiple myeloma (MM), a malignant disease of plasma cells originating in the bone marrow, is influenced significantly by genetic factors. Although plasma...
by | Jun 27, 2024 | Publications
Haematologica. 2024 Jun 27. doi: 10.3324/haematol.2024.285161. Online ahead of print. ABSTRACT Not available. PMID:38934063 | DOI:10.3324/haematol.2024.285161
by | Jun 27, 2024 | Publications
Med Clin (Barc). 2024 Jun 25:S0025-7753(24)00301-4. doi: 10.1016/j.medcli.2024.03.031. Online ahead of print. NO ABSTRACT PMID:38926039 | DOI:10.1016/j.medcli.2024.03.031
by | Jun 27, 2024 | Publications
Neuromuscul Disord. 2024 Jun 6;41:51-55. doi: 10.1016/j.nmd.2024.06.002. Online ahead of print. ABSTRACT We present the case of a 79-year-old man with rapidly progressive myopathy as the initial manifestation of light chain amyloidosis associated with multiple...
